Differential tyrosine phosphorylation of fibroblast growth factor (FGF) receptor-1 and receptor proximal signal transduction in response to FGF-2 and heparin

Experimental Cell Research

Volumn 287, Issue 1, 2003, Pages 190-198

  Lundin, Lars ^a   Rönnstrand, Lars ^b   Cross, Michael ^a   Hellberg, Carina ^b   Lindahl, Ulf ^b   Claesson Welsh, Lena ^a  

^a UPPSALA UNIVERSITY   (Sweden)

^b UPPSALA UNIVERSITY   (Sweden)

Author keywords

Autophosphorylation; Dimerization; FGF receptor; Heparin; Signal transduction

Indexed keywords

ADAPTOR PROTEIN; FIBROBLAST GROWTH FACTOR 2; FIBROBLAST GROWTH FACTOR RECEPTOR 1; HEPARAN SULFATE; HEPARIN; LINK PROTEIN; PEPTIDE DERIVATIVE; PHOSPHOLIPASE C; PHOSPHOTRANSFERASE; PROTEIN; PROTEIN SHB; TRYPTIC PHOSPHOPEPTIDE; TYROSINE; UNCLASSIFIED DRUG;

ANIMAL CELL; ARTICLE; CARBOXY TERMINAL SEQUENCE; CELL STIMULATION; CHO CELL; CONTROLLED STUDY; DIMERIZATION; ENZYME ACTIVATION; ENZYME SUBUNIT; MOLECULE; NONHUMAN; PRIORITY JOURNAL; PROTEIN BINDING; PROTEIN DOMAIN; PROTEIN EXPRESSION; PROTEIN FOLDING; PROTEIN PHOSPHORYLATION; PROTEIN STABILITY; REGULATORY MECHANISM; SIGNAL TRANSDUCTION; SRC HOMOLOGY DOMAIN;

CRICETINAE; CRICETULUS GRISEUS;

EID: 0038544025     PISSN: 00144827     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0014-4827(03)00125-3     Document Type: Article

References (42)

1. Yamashita T., Yoshioka M., Itoh N. Identification of a novel fibroblast growth factor, FGF-23, preferentially expressed in the ventrolateral thalamic nucleus of the brain. Biochem. Biophys. Res. Commun. 277:2000;494-498.
2. Klint P., Claesson-Welsh L. Signal transduction by fibroblast growth factor receptors. Front. Biosci. 4:1999;D165-177.
3. Mohammadi M., Dikic I., Sorokin A., Burgess W.H., Jaye M., Schlessinger J. Identification of six novel autophosphorylation sites on fibroblast growth factor receptor 1 and elucidation of their importance in receptor activation and signal transduction. Mol. Cell. Biol. 16:1996;977-989.
4. Mohammadi M., Dionne C.A., Li W., Li N., Spivak T., Honegger A.M., Jaye M., Schlessinger J. Point mutation in FGF receptor eliminates phosphatidylinositol hydrolysis without affecting mitogenesis. Nature. 358:1992;681-684.
5. Cross M.J., Claesson-Welsh L. FGF and VEGF function in angiogenesis signalling pathways, biological responses and therapeutic inhibition . Trends Pharmacol. Sci. 22:2001;201-207.
6. Larsson H., Klint P., Landgren E., Claesson-Welsh L. Fibroblast growth factor receptor-1 mediated endothelial cell proliferation is dependent on the Src homology (SH) 2/SH3 domain-containing adaptor protein Crk. J. Biol. Chem. 274:1999;25726-25734.
7. Ong S.H., Guy G.R., Hadari Y.R., Laks S., Gotoh N., Schlessinger J., Lax I. FRS2 proteins recruit intracellular signaling pathways by binding to diverse targets on fibroblast growth factor and nerve growth factor receptors. Mol. Cell. Biol. 20:2000;979-989.
8. Divecha N., Irvine R.F. Phospholipid signaling. Cell. 80:1995;269-278.
9. Cross M.J., Lu L., Magnusson P., Nyqvist D., Holmqvist K., Welsh M., Claesson-Welsh L. The Shb adaptor protein binds to tyrosine 766 in the FGFR-1 and regulates the Ras/MEK/MAPK pathway via FRS2 phosphorylation in endothelial cells. Mol. Biol. Cell. 13:2002;2881-2893.
10. York R.D., Yao H., Dillon T., Ellig C.L., Eckert S.P., McCleskey E.W., Stork P.J. Rapl mediates sustained MAP kinase activation induced by nerve growth factor. Nature. 392:1998;622-626.
11. Meakin S.O., MacDonald J.I., Gryz E.A., Kubu C.J., Verdi J.M. The signaling adapter FRS-2 competes with Shc for binding to the nerve growth factor receptor TrkA. A model for discriminating proliferation and differentiation. J. Biol. Chem. 274:1999;9861-9870.
12. Hadari Y.R., Kouhara H., Lax I., Schlessinger J. Binding of Shp2 tyrosine phosphatase to FRS2 is essential for fibroblast growth factor-induced PC12 cell differentiation. Mol. Cell. Biol. 18:1998;3966-3973.
13. Lundin L., Larsson H., Kreuger J., Kanda S., Lindahl U., Salmivirta M., Claesson-Welsh L. Selectively desulfated heparin inhibits fibroblast growth factor-induced mitogenicity and angiogenesis. J. Biol. Chem. 275:2000;24653-24660.
14. Guimond S., Maccarana M., Olwin B.B., Lindahl U., Rapraeger A.C. Activating and inhibitory heparin sequences for FGF-2 (basic FGF). Distinct requirements for FGF-1, FGF-2, and FGF-4. J. Biol. Chem. 268:1993;23906-23914.
15. Rapraeger A.C., Krufka A., Olwin B.B. Requirement of heparan sulfate for bFGF-mediated fibroblast growth and myoblast differentiation. Science. 252:1991;1705-1708.
16. Pye D.A., Vives R.R., Turnbull J.E., Hyde P., Gallagher J.T. Heparan sulfate oligosaccharides require 6-O-sulfation for promotion of basic fibroblast growth factor mitogenic activity. J. Biol. Chem. 273:1998;22936-22942.
17. Roghani M., Mansukhani A., Dell'Era P., Bellosta P., Basilico C., Rifkin D.B., Moscatelli D. Heparin increases the affinity of basic fibroblast growth factor for its receptor but is not required for binding. J. Biol. Chem. 269:1994;3976-3984.
18. Spivak-Kroizman T., Lemmon M.A., Dikic I., Ladbury J.E., Pinchasi D., Huang J., Jaye M., Crumley G., Schlessinger J., Lax I. Heparin-induced oligomerization of FGF molecules is responsible for FGF receptor dimerization, activation, and cell proliferation. Cell. 79:1994;1015-1024.
19. Pellegrini L., Burke D.F., von Delft F., Mulloy B., Blundell T.L. Crystal structure of fibroblast growth factor receptor ectodomain bound to ligand and heparin. Nature. 407:2000;1029-1034.
20. Schlessinger J., Plotnikov A.N., Ibrahimi O.A., Eliseenkova A.V., Yeh B.K., Yayon A., Linhardt R.J., Mohammadi M. Crystal structure of a ternary FGF-FGFR-heparin complex reveals a dual role for heparin in FGFR binding and dimerization. Mol. Cell. 6:2000;743-750.
21. Delehedde M., Seve M., Sergeant N., Wartelle I., Lyon M., Rudland P.S., Fernig D.G. Fibroblast growth factor-2 stimulation of p42/44MAPK phosphorylation and ikappa B degradation is regulated by heparan sulfate/heparin in rat mammary fibroblasts. J. Biol. Chem. 275:2000;33905-33910.
22. Wennstrom S., Sandstrom C., Claesson-Welsh L. cDNA cloning and expression of a human FGF receptor which binds acidic and basic FGF. Growth Factors. 4:1991;197-208.
23. Leevers S.J., Marshall C.J. Activation of extracellular signal-regulated kinase, ERK2, by p21ras oncoprotein. EMBO J. 11:1992;569-574.
24. Arteaga C.L., Johnson M.D., Todderud G., Coffey R.J., Carpenter G., Page D.L. Elevated content of the tyrosine kinase substrate phospholipase C-gamma 1 in primary human breast carcinomas. Proc. Natl. Acad. Sci. USA. 88:1991;10435-10439.
25. Karlsson T., Welsh M. Apoptosis of NIH3T3 cells overexpressing the Src homology 2 domain protein Shb. Oncogene. 13:1996;955-961.
26. Esko J.D. Genetic analysis of proteoglycan structure, function and metabolism. Curr. Opin. Cell Biol. 3:1991;805-816.
27. Landgren E., Blume-Jensen P., Courtneidge S.A., Claesson-Welsh L. Fibroblast growth factor receptor-1 regulation of Src family kinases. Oncogene. 10:1995;2027-2035.
28. Plevin R., Palmer S., Gardner S.D., Wakelam M.J. Regulation of bombesin-stimulated inositol 1,4,5-trisphosphate generation in Swiss 3T3 fibroblasts by a guanine-nucleotide-binding protein. Biochem. J. 268:1990;605-610.
29. Ito N., Wernstedt C., Engstrom U., Claesson-Welsh L. Identification of vascular endothelial growth factor receptor-1 tyrosine phosphorylation sites and binding of SH2 domain-containing molecules. J. Biol. Chem. 273:1998;23410-23418.
30. Boyle W.J., van der Geer P., Hunter T. Phosphopeptide mapping and phosphoamino acid analysis by two-dimensional separation on thin-layer cellulose plates. Methods Enzymol. 201:1991;110-149.
31. Wang J.K., Xu H., Li H.C., Goldfarb M. Broadly expressed SNT-like proteins link FGF receptor stimulation to activators of Ras. Oncogene. 13:1996;721-729.
32. Pantoliano M.W., Horlick R.A., Springer B.A., Van Dyk D.E., Tobery T., Wetmore D.R., Lear J.D., Nahapetian A.T., Bradley J.D., Sisk W.P. Multivalent ligand-receptor binding interactions in the fibroblast growth factor system produce a cooperative growth factor and heparin mechanism for receptor dimerization. Biochemistry. 33:1994;10229-10248.
33. Springer B.A., Pantoliano M.W., Barbera F.A., Gunyuzlu P.L., Thompson L.D., Herblin W.F., Rosenfeld S.A., Book G.W. Identification and concerted function of two receptor binding surfaces on basic fibroblast growth factor required for mitogenesis. J. Biol. Chem. 269:1994;26879-26884.
34. Plotnikov A.N., Schlessinger J., Hubbard S.R., Mohammadi M. Structural basis for FGF receptor dimerization and activation. Cell. 98:1999;641-650.
35. Lin X., Buff E.M., Perrimon N., Michelson A.M. Heparan sulfate proteoglycans are essential for FGF receptor signaling during Drosophila embryonic development. Development. 126:1999;3715-3723.
36. Moscatelli D. Basic fibroblast growth factor (bFGF) dissociates rapidly from heparan sulfates but slowly from receptors. Implications for mechanisms of bFGF release from pericellular matrix. J. Biol. Chem. 267:1992;25803-25809.
37. Nugent M.A., Edelman E.R. Kinetics of basic fibroblast growth factor binding to its receptor and heparan sulfate proteoglycan a mechanism for cooperactivity . Biochemistry. 31:1992;8876-8883.
38. B. Casu, U. Lindahl, Adv. Carbohydr. Chem. Biochem. (2001), in press,
39. Maccarana M., Sakura Y., Tawada A., Yoshida K., Lindahl U. Domain structure of heparan sulfates from bovine organs. J. Biol. Chem. 271:1996;17804-17810.
40. Feyzi E., Saldeen T., Larsson E., Lindahl U., Salmivirta M. Age-dependent modulation of heparan sulfate structure and function. J. Biol. Chem. 273:1998;13395-13398.
41. van Kuppevelt T.H., Dennissen M.A., van Venrooij W.J., Hoet R.M., Veerkamp J.H. Generation and application of type-specific anti-heparan sulfate antibodies using phage display technology. Further evidence for heparan sulfate heterogeneity in the kidney. J. Biol. Chem. 273:1998;12960-12966.
42. Born J., Jann K., Assmann K.J., Lindahl U., Berden J.H. N-Acetylated domains in heparan sulfates revealed by a monoclonal antibody against the Escherichia coli K5 capsular polysaccharide. Distribution of the cognate epitope in normal human kidney and transplant kidney with chronic vascular rejection. J. Biol. Chem. 271:1996;22802-22809.